CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 391 filers reported holding CRISPR THERAPEUTICS AG in Q4 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,399 | +12.4% | 52,006 | +4.5% | 0.11% | +7.8% |
| Q2 2022 | $3,025 | -47.7% | 49,776 | -46.0% | 0.10% | -28.5% |
| Q1 2022 | $5,781 | +60.4% | 92,106 | +93.7% | 0.14% | +94.6% |
| Q4 2021 | $3,603 | -29.0% | 47,541 | +4.9% | 0.07% | -22.9% |
| Q3 2021 | $5,074 | -38.9% | 45,330 | -11.6% | 0.10% | -38.1% |
| Q2 2021 | $8,304 | +41.2% | 51,292 | +6.2% | 0.16% | +24.0% |
| Q1 2021 | $5,882 | -32.8% | 48,275 | -15.6% | 0.12% | -36.5% |
| Q4 2020 | $8,757 | +166.2% | 57,197 | +45.4% | 0.20% | +75.9% |
| Q3 2020 | $3,290 | +2.6% | 39,334 | -9.8% | 0.11% | -3.4% |
| Q2 2020 | $3,206 | +121.6% | 43,625 | +27.8% | 0.12% | +48.7% |
| Q1 2020 | $1,447 | -31.3% | 34,127 | -1.3% | 0.08% | -19.6% |
| Q4 2019 | $2,106 | +48.5% | 34,582 | 0.0% | 0.10% | +24.4% |
| Q3 2019 | $1,418 | -5.7% | 34,582 | +8.3% | 0.08% | +5.4% |
| Q2 2019 | $1,504 | +28.9% | 31,927 | -2.2% | 0.07% | +17.5% |
| Q1 2019 | $1,167 | +16.7% | 32,657 | -6.7% | 0.06% | -11.3% |
| Q4 2018 | $1,000 | -52.4% | 34,992 | -26.1% | 0.07% | -37.7% |
| Q3 2018 | $2,100 | -62.3% | 47,342 | -50.1% | 0.11% | -66.1% |
| Q2 2018 | $5,570 | +40.5% | 94,791 | +9.3% | 0.34% | +17.5% |
| Q1 2018 | $3,965 | +19.6% | 86,743 | -38.5% | 0.29% | +9.6% |
| Q4 2017 | $3,314 | -29.7% | 141,140 | -46.5% | 0.26% | -33.6% |
| Q3 2017 | $4,713 | +69.2% | 263,746 | +51.7% | 0.39% | +52.9% |
| Q2 2017 | $2,786 | – | 173,907 | – | 0.26% | – |
Download | ||||||